✦ LIBER ✦

Gene transfer therapy in cancer

✍ Scribed by Mr. S. Dorudi; J. M. A. Northover; R. G. Vile

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 922 KB
Volume: 80
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800800507

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy for cancer

✍ Bert O'Malley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Transfer factor therapy in patients with

Transfer factor therapy in patients with cancer

✍ R. Mark Vetto; Denis R. Burger; James E. Nolte; Arthur A. Vandenbark; Harvey W. 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

The objective of this study was to utilize transfer factor to stimulate cell-mediated immunity to specific tumor antigens in cancer patients. Thirty-five selected patients with advanced recurrent cancer, who were not suitable for further conventional therapy, were treated with transfer factor. Trans

Progress in antiangiogenic gene therapy

Progress in antiangiogenic gene therapy of cancer

✍ Andrew L. Feldman; Steven K. Libutti 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

## BACKGROUND. Because tumors require angiogenesis for growth, inhibiting angiogenesis is a promising strategy for treating cancer patients. Although numerous endogenous angiogenesis inhibitors have been discovered, the clinical evaluation of these agents has been hindered by high dose requirement

Prodrug activation enzymes in cancer gen

Prodrug activation enzymes in cancer gene therapy

✍ Manish Aghi; Fred Hochberg; Xandra O. Breakefield 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Among the broad array of genes that have been evaluated for tumor therapy, those encoding prodrug activation enzymes are especially appealing as they directly complement ongoing clinical chemotherapeutic regimes. These enzymes can activate prodrugs that have low inherent toxicity using both bacteria

Gene therapy for pancreatic cancer

✍ Shin Takeda; Akimasa Nakao; Koji Miyoshi; Hiroshi Takagi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 2 views

It has been approximately 7 years since the introduction of gene therapy. Since conventional procedures such as surgery, chemotherapy, and radiotherapy have had limited therapeutic value for cancer patients, the evolution of gene therapy seems a promising alternative to many researchers and clinicia

Gene therapy for lung cancer

✍ Eric M. Toloza; Michael A. Morse; H. Kim Lyerly 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract Lung cancer patients suffer a 15% overall survival despite advances in chemotherapy, radiation therapy, and surgery. This unacceptably low survival rate is due to the usual finding of advanced disease at diagnosis. However, multimodality strategies using conventional therapies only mini